News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
874,248 Results
Type
Article (88197)
Company Profile (731)
Press Release (785295)
Multimedia
Podcasts (217)
Webinars (34)
Section
Business (233342)
Career Advice (4151)
Deals (39912)
Drug Delivery (162)
Drug Development (91477)
Employer Resources (206)
FDA (18441)
Job Trends (17453)
News (398103)
Policy (39974)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3030)
Academic (1)
Accelerated approval (45)
Adcomms (33)
Allergies (172)
Alliances (56975)
ALS (206)
Alzheimer's disease (1877)
Antibody-drug conjugate (ADC) (410)
Approvals (18696)
Artificial intelligence (682)
Autoimmune disease (242)
Automation (52)
Bankruptcy (405)
Best Places to Work (12618)
BIOSECURE Act (23)
Biosimilars (219)
Biotechnology (453)
Bladder cancer (183)
Brain cancer (72)
Breast cancer (719)
Cancer (5585)
Cardiovascular disease (490)
Career advice (3581)
Career pathing (46)
CAR-T (326)
CDC (64)
Celiac Disease (2)
Cell therapy (887)
Cervical cancer (43)
Clinical research (77753)
Collaboration (2062)
Company closure (6)
Compensation (1312)
Complete response letters (87)
COVID-19 (3005)
CRISPR (110)
C-suite (1033)
Cystic fibrosis (158)
Data (7230)
Decentralized trials (3)
Denatured (81)
Depression (172)
Dermatology (59)
Diabetes (571)
Diagnostics (7381)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (334)
Drug pricing (225)
Drug shortages (33)
Duchenne muscular dystrophy (283)
Earnings (101113)
Editorial (69)
Employer branding (25)
Employer resources (174)
Events (136146)
Executive appointments (1081)
FDA (21968)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (30)
Funding (1709)
Gene editing (236)
Generative AI (64)
Gene therapy (743)
GLP-1 (1166)
Government (5473)
Grass and pollen (8)
Guidances (398)
Healthcare (20973)
HIV (79)
Huntington's disease (58)
IgA nephropathy (95)
Immunology and inflammation (318)
Immuno-oncology (92)
Indications (158)
Infectious disease (3339)
Inflammatory bowel disease (222)
Inflation Reduction Act (17)
Influenza (136)
Intellectual property (281)
Interviews (817)
IPO (17967)
IRA (58)
Job creations (5204)
Job search strategy (2869)
JPM (73)
Kidney cancer (19)
Labor market (104)
Layoffs (662)
Leadership (44)
Legal (10154)
Liver cancer (105)
Longevity (29)
Lung cancer (750)
Lymphoma (416)
Machine learning (54)
Management (66)
Manufacturing (987)
MASH (194)
Medical device (15093)
Medtech (15171)
Mergers & acquisitions (23086)
Metabolic disorders (1542)
mRNA (216)
Multiple sclerosis (178)
NASH (24)
Neurodegenerative disease (431)
Neuropsychiatric disorders (112)
Neuroscience (3381)
Neurotech (1)
NextGen: Class of 2026 (7692)
Non-profit (5127)
Now hiring (74)
Obesity (743)
Opinion (351)
Ovarian cancer (190)
Pain (242)
Pancreatic cancer (267)
Parkinson's disease (360)
Partnered (37)
Patents (574)
Patient recruitment (617)
Peanut (65)
People (67286)
Pharmaceutical (128)
Pharmacy benefit managers (35)
Phase 1 (24026)
Phase 2 (33776)
Phase 3 (25412)
Pipeline (7271)
Policy (361)
Postmarket research (3553)
Preclinical (10778)
Press Release (72)
Prostate cancer (284)
Psychedelics (59)
Radiopharmaceuticals (327)
Rare diseases (1100)
Real estate (7444)
Recruiting (81)
Regulatory (29589)
Reports (73)
Research institute (2744)
Resumes & cover letters (653)
Rett syndrome (33)
RNA editing (22)
RSV (90)
Schizophrenia (175)
Series A (291)
Series B (213)
Service/supplier (27)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (185)
Sponsored (52)
Startups (4348)
State (2)
Stomach cancer (20)
Supply chain (123)
Tariffs (96)
The Weekly (133)
Vaccines (1210)
Venture capital (110)
Weight loss (497)
Women's health (115)
Worklife (23)
Date
Last 7 days (667)
Last 30 days (2569)
Last 365 days (31595)
2026 (8426)
2025 (31909)
2024 (37595)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1291)
Alabama (99)
Alaska (7)
Arizona (366)
Arkansas (15)
Asia (51821)
Australia (9101)
California (12671)
Canada (3582)
China (1319)
Colorado (542)
Connecticut (538)
Delaware (376)
Europe (119169)
Florida (1892)
Georgia (407)
Hawaii (4)
Idaho (69)
Illinois (1041)
India (87)
Indiana (578)
Iowa (24)
Japan (499)
Kansas (138)
Kentucky (48)
Louisiana (43)
Maine (78)
Maryland (1560)
Massachusetts (9250)
Michigan (364)
Minnesota (710)
Mississippi (7)
Missouri (142)
Montana (36)
Nebraska (30)
Nevada (141)
New Hampshire (88)
New Jersey (3383)
New Mexico (32)
New York (3354)
North Carolina (1721)
North Dakota (10)
Northern California (6200)
Ohio (377)
Oklahoma (25)
Oregon (52)
Pennsylvania (2539)
Puerto Rico (27)
Rhode Island (52)
South America (1667)
South Carolina (77)
South Dakota (1)
Southern California (4932)
Tennessee (202)
Texas (2005)
United States (45344)
Utah (380)
Vermont (1)
Virginia (315)
Washington D.C. (85)
Washington State (1039)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
874,248 Results for "bio options inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
INmune Bio Inc. Announces 2025 Results and Provides Business Update
March 30, 2026
·
15 min read
Layoffs
BioAtla Axes 70% of Staff, Explores Strategic Options
Less than a year after cutting roughly 30% of its employees, BioAtla is letting go of an even larger chunk of its workforce as it considers its future, which could include strategic partnerships and selling off assets.
March 2, 2026
·
1 min read
·
Angela Gabriel
Press Releases
Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New “AutoResearch” Milestone Signals the Rise of Autonomous Research Agents
Open-source breakthrough demonstrates AI agents can run 100+ experiments overnight-reinforcing the agentic R&D paradigm Researgency.ai is bringing to life sciences with Kala Bio (KALA)
March 11, 2026
·
6 min read
Press Releases
INmune Bio Inc. to Report Year End 2025 Financial Results and Provide Corporate Update on Monday, March 30th.
March 24, 2026
·
3 min read
Press Releases
Takara Bio USA, Inc. Collaborates with Illumina on Spatial Transcriptomics Workflow, Details Presented at AGBT 2026
February 26, 2026
·
3 min read
Press Releases
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
February 10, 2026
·
4 min read
Press Releases
Etienna Bio, Inc. Announces Formation of Scientific Advisory Board with Renowned UMass Chan Leaders
February 12, 2026
·
4 min read
Press Releases
ABS Bio, Inc. acquires Cureline, Inc. to strengthen support of biopharma drug discovery
January 7, 2026
·
1 min read
Press Releases
Zydus Lifesciences Limited completes the acquisition of Agenus Inc.'s biologics manufacturing facilities, launches Zylidac Bio LLC in the U.S.
January 16, 2026
·
3 min read
Press Releases
D3 Bio to Showcase Its Innovative KRAS Pipeline at AACR 2026, Including an Oral Presentation at Clinical Plenary Session
March 20, 2026
·
4 min read
1 of 87,425
Next
